New Distribution Agreements (4237C)
March 07 2011 - 1:01AM
UK Regulatory
TIDMCTN
RNS Number : 4237C
ClearStream Technologies Group PLC
07 March 2011
For Immediate Release 7 March 2011
ClearStream Technologies Group plc
Expansion of Global Distributor Network for Coronary and
Peripheral Portfolios:
New Distributors appointed in Scandinavia, the Middle East and
Asia Pacific;
ClearStream Technologies Group plc ("ClearStream"), the
specialist supplier of medical devices used in coronary and
peripheral interventional procedures, is pleased to announce that
it has recently signed a number of new Distribution Agreements
which will significantly enhance its global distribution network.
New markets served include Norway, Denmark and Sweden in
Scandinavia, Egypt and Iran in the Middle East and Indonesia and
The Philippines in the Asia Pacific region.
ClearStream has appointed VingMed Group, based in Oslo, to
distribute its range of Peripheral products throughout Norway,
Sweden and Denmark which together account for over 15,000 lower
limb procedures each year. VingMed has a well established sales
infrastructure, supplying medical devices across each of these key
Scandinavian markets.
In the Middle East, EgyptCare, based in Cairo and AGP in Teheran
have been appointed for the distribution of both coronary and
peripheral product portfolios across the two largest markets in the
region, Egypt and Iran, whilst in Asia Pacific, Mulya Husada Jaya
of Surabaya, Indonesia will also distribute both ranges. In the
Philippines, ClearStream has appointed Biodevices Inc. of Manila,
which has an extensive sales and marketing infrastructure already
well established across the territory.
Commenting on the expanded Distribution Network, ClearStream's
CEO Andy Jones said:
"The impact of our new dedicated Distributor Management Team and
structure is already in evidence with the addition of these five
new distributors in key target markets. Our aggressive market entry
plans have already made rapid progress in these strategically
important markets.
"We continue to target and develop global markets where diabetes
is a widely diagnosed disease state and where the opportunities to
grow sales across our product portfolios are significant."
For further information:
ClearStream Technologies Group Tel: + 353 (0) 53 923
plc 7111
Andrew Jones, CEO
Winningtons Financial Tel: + 44 (0) 117 985
8989
Paul Vann
FinnCap Tel: + 44 (0) 20 7600
1658
Marc Young, Corporate Finance
Charlotte Stranner, Corporate
Finance
Stephen Norcross, Corporate
Broking
About ClearStream:
ClearStream, based in Enniscorthy, Co Wexford, Ireland, is an
innovative maker of medical devices used in peripheral (lower limb)
and coronary interventional procedures, including catheters and
stents. Its products are sold under ClearStream's own brands and
are also supplied to Original Equipment Manufacturers.
The Company is listed on the AIM market of the London Stock
Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRFMGGFVNDGMZG
Clearstream (LSE:CTN)
Historical Stock Chart
From May 2024 to Jun 2024
Clearstream (LSE:CTN)
Historical Stock Chart
From Jun 2023 to Jun 2024